コーンビームCT
AT A GLANCE
CBCTのパイオニア
従来型からAIベースのCBCTへ
GEヘルスケアは複雑な進化に対応していくためのガイドを提供していきます。
GEヘルスケアは、インターベンションのパイオニアであるだけでなく、継続的な革新を通じて、その課題と進化に対応するソリューションを提供しています。CBCTの進化
診療業務を最適化し微調整することで、患者のアウトカムと手技の操作性を向上
幅広いOptionをご用意し、日常診療における正確性、安全性、信頼性の実現をサポートし、より良い診療に貢献します。
CleaRecon DL3,4
AI時代の到来
さらなる高画質へ
3D CT HD5
診断、治療計画、インターベンション治療、そして治療のフォローアップの最適化
Motion Freeze6,7
呼吸によるアーチファクトを補正し、再撮影による追加の被ばくを避けられます
MAR11
金属アーチファクトを低減し、画質を最適化
参考資料
* Product may not be available in all countries. Refer to your sales representatives for more information.
Allia refers to AlliaTM system.
1. Solim LA et al. The efficacy of cone-beam computed tomography-guided transcatheter arterial chemoembolization in hepatocellular carcinoma survival: A systematic review. J Clin Imaging Sci. 2024 ;14:25.
2. Zhong BY et al. Application of Cone-beam Computed Tomography in Interventional Therapies for Liver Malignancy: A Consensus Statement by the Chinese College of Interventionalists. J Clin Transl Hepatol. 2024;12(10):886-891.
3. Designed to be used with AlliaTM systems.
4. CleaRecon DL is an option in 3DXR designed to be used with Allia systems and requires AW workstation with Volume Viewer. May not be available in all countries. Not CE marked.
5. 3D CT HD is an option sold separately. Includes 3DXR. Requires AW workstation and Volume Viewer.
6. The improvement related to Motion Freeze depends on the acquisition conditions, table position, patient, type of motion, anatomical location and clinical practice.
7. Motion Freeze is an optional feature of 3DXR (part of GE HealthCare vascular systems IGS 5, IGS 6 and IGS 7 or IGS 7OR). Motion Freeze and 3DXR may not be available in all markets. Refer to your sales representative.
8. Motion Freeze can help salvage CBCT acquisitions by refining and increasing small contrasted structures in CBCT images that would have otherwise been discarded due to involuntary respiratory motion artifacts.
9. By potentially reducing the need to repeat CBCT acquisitions, Motion Freeze may help minimize radiation dose and contrast media injection.
10. By helping to salvage, rather than discard, initial CBCT images, Motion Freeze enables access to advanced solutions.
11. MAR is an optional feature of 3DXR, which is included in 3D CT HD, a 3D application of the GE HealthCare vascular system IGS 5, IGS 6, IGS 7 and IGS 7OR, and removes metal artifacts generated by coils in the CBCT field of view. 3D CT HD and MAR may not be available in all markets. Refer your sales representative.
12. 3D CT HD is an option sold separately. Includes 3DXR. Requires AW workstation and Volume Viewer.
13. Product may not be available in all countries. Refer to your sales representative for more information.
14. Embo ASSIST AI solution includes FlightPlan for embolization and requires AW workstation with Volume Viewer, Volume Viewer InnovaTM, Vision 2, VesselIQTM Xpress, AutoBoneTM Xpress. These applications are sold seperatley and may not be available in all countries.
15. Liver ASSIST Virtual Parenchyma solution includes Hepatic VCAR and FlightPlan for Liver with Parenchyma Analysis option and requires AW workstation with Volume Viewer, Volume Viewer Innova, Vision 2, VesselIQ Xpress, AutoBone Xpress. これらのアプリケーションは別売りです。 FlightPlan for Liver with Parenchyma Analysis option may not be available for sale in all countries. Please refer to your sales representative for more information. Liver ASSIST Virtual Parenchyma is designed to attain the same performance outcomes of FlightPlan for Liver. The above Liver ASSIST performance outcomes reflect the results of three published journal articles (a,b,c) that used previous version of FlightPlan for Liver software. The results of these published studies do not necessarily represent individual performance of FlightPlan for Liver. a) Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver – Bapst et al. Cardiovasc Intervent Radiol. 2016. b) Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography –Minami et al. Liver Cancer. 2014. c) Clinical utility and limitations of tumor-feeder detection software for liver cancer embolization. Iwazawa et al. European Journal of Radiology. 2013.
Allia refers to AlliaTM system.
1. Solim LA et al. The efficacy of cone-beam computed tomography-guided transcatheter arterial chemoembolization in hepatocellular carcinoma survival: A systematic review. J Clin Imaging Sci. 2024 ;14:25.
2. Zhong BY et al. Application of Cone-beam Computed Tomography in Interventional Therapies for Liver Malignancy: A Consensus Statement by the Chinese College of Interventionalists. J Clin Transl Hepatol. 2024;12(10):886-891.
3. Designed to be used with AlliaTM systems.
4. CleaRecon DL is an option in 3DXR designed to be used with Allia systems and requires AW workstation with Volume Viewer. May not be available in all countries. Not CE marked.
5. 3D CT HD is an option sold separately. Includes 3DXR. Requires AW workstation and Volume Viewer.
6. The improvement related to Motion Freeze depends on the acquisition conditions, table position, patient, type of motion, anatomical location and clinical practice.
7. Motion Freeze is an optional feature of 3DXR (part of GE HealthCare vascular systems IGS 5, IGS 6 and IGS 7 or IGS 7OR). Motion Freeze and 3DXR may not be available in all markets. Refer to your sales representative.
8. Motion Freeze can help salvage CBCT acquisitions by refining and increasing small contrasted structures in CBCT images that would have otherwise been discarded due to involuntary respiratory motion artifacts.
9. By potentially reducing the need to repeat CBCT acquisitions, Motion Freeze may help minimize radiation dose and contrast media injection.
10. By helping to salvage, rather than discard, initial CBCT images, Motion Freeze enables access to advanced solutions.
11. MAR is an optional feature of 3DXR, which is included in 3D CT HD, a 3D application of the GE HealthCare vascular system IGS 5, IGS 6, IGS 7 and IGS 7OR, and removes metal artifacts generated by coils in the CBCT field of view. 3D CT HD and MAR may not be available in all markets. Refer your sales representative.
12. 3D CT HD is an option sold separately. Includes 3DXR. Requires AW workstation and Volume Viewer.
13. Product may not be available in all countries. Refer to your sales representative for more information.
14. Embo ASSIST AI solution includes FlightPlan for embolization and requires AW workstation with Volume Viewer, Volume Viewer InnovaTM, Vision 2, VesselIQTM Xpress, AutoBoneTM Xpress. These applications are sold seperatley and may not be available in all countries.
15. Liver ASSIST Virtual Parenchyma solution includes Hepatic VCAR and FlightPlan for Liver with Parenchyma Analysis option and requires AW workstation with Volume Viewer, Volume Viewer Innova, Vision 2, VesselIQ Xpress, AutoBone Xpress. これらのアプリケーションは別売りです。 FlightPlan for Liver with Parenchyma Analysis option may not be available for sale in all countries. Please refer to your sales representative for more information. Liver ASSIST Virtual Parenchyma is designed to attain the same performance outcomes of FlightPlan for Liver. The above Liver ASSIST performance outcomes reflect the results of three published journal articles (a,b,c) that used previous version of FlightPlan for Liver software. The results of these published studies do not necessarily represent individual performance of FlightPlan for Liver. a) Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver – Bapst et al. Cardiovasc Intervent Radiol. 2016. b) Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography –Minami et al. Liver Cancer. 2014. c) Clinical utility and limitations of tumor-feeder detection software for liver cancer embolization. Iwazawa et al. European Journal of Radiology. 2013.